Sitting Down With… Margaret Hamburg, President-elect AAAS, Foreign secretary of National Academy of Medicine

Geert Cauwenbergh believes that RNAi could be the therapeutic of the future.

Cybersecurity is an aspect of business infrastructure that needs to be taken seriously.

Can the microbiome predict the likelihood of chemotherapy side effects?

Over 90 percent of drugs fail to make it to market. What can the industry do to change that?

Could body-on-chip platforms eventually replace current pre-clinical animal models?

Pharma’s 2022 growth forecast has been reduced for the first time in a decade.

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?

The EFPIA highlights the risks of disrupting UK–EU medicine supply chains.

The FDA has approved a pill with the ability to track patient compliance.